Keeler THomas Management »

Halozyme Therapeutics shares owned by Keeler THomas Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Keeler THomas Management from 13F filings

Historical chart of Keeler THomas Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Keeler THomas Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Keeler THomas Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 19k 73.34
2025-06-30 $983k 19k 52.02

More positions owned by Keeler THomas Management

Ishares Tr Ibonds Dec25 Etf (Principal) (IBDQ)
Ishares Tr Ibonds 2026 Term (IBHF)
Ishares Tr Ibonds 28 Tr Hi (IBHH)
Ishares Tr Ibonds 2027 Term (IBHG)
Ishares Tr Ibonds Dec2026 (Principal) (IBDR)
Ishares Tr Ibonds 29 Tr Hi (IBHI)
Ishares Tr Ibonds 25 Trm Hg (IBHE)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Broad Usd High (USHY)
Janus Detroit Str Tr B-bbb Clo Etf (JBBB)
Ishares Tr Ibonds 27 Etf (Principal) (IBDS)
Ishares Tr Ibonds 25 Trm Ts (IBTF)
Ishares Tr Ibonds Dec 2031 (IBDW)
Ishares Tr Ibonds Dec 2030 (IBDV)

View all positions for Keeler THomas Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
UBS Group
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Morgan Stanley
Macquarie Group
Federated Investors
Congress Asset Management

View all funds holding Halozyme Therapeutics